Research Program
What Does Our Research Program Consist Of?
We have been an active clinical research site since 1996. We have participated in over 80 studies in Alzheimer’s disease. We assist in the development of pharmaceuticals that hold promise to improve symptoms and/or alter the course of this disease. We are involved in early phase trials as well as large multinational trials. All studies are conducted according to national and international regulations and codes of conduct, and are approved by independent research ethic boards. Your participation in research is voluntary. There are no fees to participate in research. Study medication is provided to you free of charge.
Why Participate In Clinical Research?
- Access to promising treatments not otherwise available
- Access to new medications without cost
- Access to specialist care and regular monitoring by an expert team
- Opportunity to contribute to scientific knowledge and to improve outcomes for oneself and for others
To Learn More or to Participate:
Call our research line directly at 416 386-9606, or email us at research@memorydisorders.ca
Alternatively, have your doctor refer you for research options.
Who Is Eligible?
To be considered for research, you must be:
- Age 50+
- Able to communicate in English
- Able to come to appointments with a friend or family member.
While participating in research, individuals are able to remain on their regular medications.
What Is Involved in Being Part Of A Study
The process begins with a discussion of a study of potential interest to you. We explain the purpose and nature of the study, the time requirements, and the possible risks and benefits. If you wish to proceed, you will sign an Information & Consent Form (ICF) and will be given a copy to take home. The person accompanying you plays an important supportive role and will be asked to participate along with you.
Screening measures will be undertaken to ensure that the proposed study is safe and suitable for you. Screening typically includes: a review of your general health and medications; memory tests; blood tests; and an ECG. A scan of the brain may also be ordered. All of these tests will be provided at no cost to you.
Following successful screening, you will start taking study medication. Most studies are designed to compare a new treatment with the best existing treatment or with placebo. These details will be carefully explained.
A schedule of study visits will be provided. At each visit, you will be interviewed and undergo assessments to track your progress. While enrolled in a study, you will continue taking your regular medications. We will keep your family doctor informed of your progress through faxed reports. Results of studies you are involved in will be shared with you as these results become available.
Once you reach the final study visit, there may be an opportunity to join an “open label study” in which the study drug is provided to you for an additional period of time.
What Studies Are Currently Being Offered?
To download a list of our current trials click on the link below:
TMP Current Clinical Trials - last updated February 13, 2012
For more information on specific trials, go to ClinicalTrials.gov - Dementia Trials
